tiprankstipranks
Trending News
More News >
Allianz SE Unsponsored ADR (ALIZY)
OTHER OTC:ALIZY
US Market

Allianz SE Unsponsored ADR (ALIZY) Earnings Dates, Call Summary & Reports

Compare
170 Followers

Earnings Data

Report Date
May 19, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.84
Last Year’s EPS
0.74
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlights strong, broad‑based operational delivery across P&C, Life & Health and Asset Management with record revenue, operating profit, robust capital generation (Solvency II 218%), record flows and improved productivity. Management acknowledges headwinds — chiefly FX sensitivity, claims inflation, reserve conservatism and exposure to nat‑cat and private credit scrutiny — but presents clear mitigation actions (prudent reserving, strong liquidity, buyback/dividend, tech investment, focus on retention and resilience). Overall positives substantially outweigh the challenges.
Company Guidance
Allianz kept its traditional outlook framework and anchored 2026 guidance to last year’s operating profit of €17.4bn ± €1bn (midpoint implying roughly +9% versus the prior outlook), while reiterating Capital Markets Day targets and signalling stronger capital generation and resilience: Solvency II at 218% (YE‑2025, +~10pp y/y) with post‑stress ~197% and an expected positive Solvency II revision effect (high end of the 5–10% range from 1‑Jan‑2027); operating capital generation target 24–25% by 2027 (OCG was 25% in 2025, underlying ~22%); remittances €8.6bn (remittance ratio 89% vs 85% target); €2.5bn share buyback announced and a double‑digit dividend per share increase; 2025 highlights feeding the outlook included revenues €187bn (+8% internal volume growth), operating profit €17.4bn (+8%, ~+11% ex‑FX), core EPS +13% (vs CMD target 7–9%), ROE/core equity return ~18%/18.1%, P&C OP €9bn (+14%) with combined ratio ~92% and retail growth 9%, Life & Health OP €5.6bn with PVNBP ~€85bn, Asset Management net flows ~€139bn (organic growth 7%) and cost/income ~60–61% (AGI 60.7%), plus expense‑ratio progress in P&C (from 28.6% in 2018 to 23.9%) — all framed conservatively to allow for FX, nat‑cat and market volatility.
Record Group Revenue and Operating Profit
Group revenue reached EUR 187 billion (record) with internal volume growth of 8%. Operating profit rose more than 8% to EUR 17.4 billion (highest level ever), above the top end of the original outlook.
Strong Earnings, EPS and ROE Outperformance
Core net income / core EPS grew ~13% (above Capital Markets Day 7–9% target range). Return on equity (ROE) at ~18% (above the >17% target).
Very Strong Solvency and Capital Generation
Solvency II ratio at 218% (up ~10 percentage points year‑on‑year). Operating capital generation (OCG) reached ~25 percentage points in 2025 (management estimates sustainable baseline ~22 ppt). Post‑stress solvency around 197%.
P&C Performance: Revenue, Margin and Profit
P&C revenue hit a record EUR 87 billion (+8%); retail P&C growth 9%. Combined ratio close to 92% for the year and P&C operating profit rose ~14% to EUR 9 billion, driven by improved attritional loss ratio and prudent reserving.
Life & Health: New Business and Profitability
PVNBP nearly EUR 85 billion (highest ever) with FX‑adjusted growth >5%. New business mix strong (Protection & Health + Unit‑Linked represent ~51% of new business value). Life & Health operating profit ~EUR 5.6 billion, FX‑adjusted growth ~4%.
Asset Management: Record Flows and Outperformance
Asset Management net flows ~EUR 139 billion (record), organic growth ~7% for the year; Q4 net flows ~EUR 45 billion (record Q4). 93% of assets outperformed 3‑year benchmark. Segment cost/income ratio ~60.7% (improved), operating profit EUR 3.3 billion (FX‑adjusted +7%).
Shareholder Returns and Liquidity Actions
Dividend per share increased double‑digit (continuing a 9‑of‑10‑year trend of increases) and a EUR 2.5 billion share buyback announced. Net cash remittances EUR 8.6 billion with remittance ratio ~89%.
Productivity, Cost Reductions and Technology Investment
P&C expense ratio materially reduced from 28.6% in 2018 to 23.9% (≈5pp improvement). Management targets ongoing ~30 bps annual cost improvements. Group investing ~EUR 6.5 billion in tech and focusing GenAI on differentiated customer service and productivity gains.
Customer, Brand and Employee Strength
NPS and brand metrics improved (70% of businesses are loyalty leaders); highest ever brand/trust scores across multiple benchmarks and best‑in‑class employee motivation and work‑well indices reported.

Allianz SE Unsponsored ADR (ALIZY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ALIZY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 19, 2026
2026 (Q1)
0.84 / -
0.739
Feb 26, 2026
2025 (Q4)
0.88 / 0.85
0.65628.96% (+0.19)
Nov 14, 2025
2025 (Q3)
0.83 / 0.86
0.69324.68% (+0.17)
Aug 07, 2025
2025 (Q2)
0.76 / 0.86
0.67128.02% (+0.19)
May 15, 2025
2025 (Q1)
0.76 / 0.74
0.6976.03% (+0.04)
Feb 28, 2025
2024 (Q4)
0.66 / 0.66
0.6491.08% (<+0.01)
Nov 13, 2024
2024 (Q3)
0.68 / 0.69
0.55724.42% (+0.14)
Aug 08, 2024
2024 (Q2)
0.63 / 0.67
0.6581.98% (+0.01)
May 15, 2024
2024 (Q1)
0.61 / 0.70
0.5918.14% (+0.11)
Feb 23, 2024
2023 (Q4)
0.61 / 0.65
0.53221.99% (+0.12)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ALIZY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
$44.95$45.34+0.87%
Nov 14, 2025
$42.26$42.57+0.73%
Aug 07, 2025
$41.12$42.74+3.94%
May 15, 2025
$39.07$38.81-0.67%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Allianz SE Unsponsored ADR (ALIZY) report earnings?
Allianz SE Unsponsored ADR (ALIZY) is schdueled to report earning on May 19, 2026, TBA (Confirmed).
    What is Allianz SE Unsponsored ADR (ALIZY) earnings time?
    Allianz SE Unsponsored ADR (ALIZY) earnings time is at May 19, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ALIZY EPS forecast?
          ALIZY EPS forecast for the fiscal quarter 2026 (Q1) is 0.84.